Cardiogenesis - Corporate Information for Investors

Cardiogenesis Corporation (Ticker: CGCP.PK) is a global leader in products and technologies to treat severe angina pain. The company is located in Orange County, California. In addition to its market approved TMR therapies to treat severe angina, is currently developing new platforms for angina treatments. The Cardiogenesis development initiatives include seeking approval of minimally invasive cardiology products as well as integrated biologic and laser delivery systems .

Cardiogenesis creates products to help treat severe angina pain that affects approximately 8 million people in the U.S. and more than 100 million people Worldwide.